Monopar Therapeutics Inc (MNPR) Technical Analysis
$54.33▲10.38%
Market is closed - opens 7 PM, 16 Sep 2025
Insights
- Monopar Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Monopar Therapeutics stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Monopar Therapeutics stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Monopar Therapeutics stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 72.2 | Sell |
Stochastic | 99.8, 98.83 | Neutral |
Ultimate Oscillator | 80.59 | Sell |
Stochastic Relative Strength Index | 100.0, 95.02 | Neutral |
Moving Average Convergence Divergence | 3.23, 1.19 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 43.39 | Buy |
20 | 38.3 | Sell |
50 | 39.73 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 44.78 | Buy |
20 | 41.39 | Buy |
50 | 39.31 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 41.98 | Buy |
20 | 37.07 | Buy |
50 | 38.87 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 49.9 | Buy |
20 | 44.93 | Buy |
50 | 40.36 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 52.52 | Buy |
20 | 48.35 | Buy |
50 | 42.02 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 55.14 |
Resistance L2 | 52.47 |
Resistance L1 | 50.85 |
Pivot Point | 48.18 |
Support L1 | 46.56 |
Support L2 | 43.89 |
Support L3 | 42.27 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.